{"lastClose": 7.010000228881836, "len": 1095, "date": "2023-02-16", "alpha_1": -0.14986299387942847, "beta_1": 1.6585542795364379, "drawup_1": 1.5486725887776869, "natr_1": 12.56100263135872, "sup_1": -0.566333828445832, "res_1": 0.32667616078213807, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 58.89046975448243, "adx_1": 28.872250513753627, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.12789261051988932, "stratHoldAlpha_1": 250.91143177345967, "stratHoldDrawdown_1": -0.6333896873020146, "alpha_3mo": -0.6958658330830438, "beta_3mo": 2.0788864675041525, "drawup_3mo": 0.4608541290620036, "natr_3mo": 12.56100263135872, "sup_3mo": -0.10413692386486693, "res_3mo": 0.049928635414991575, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 34.035087190946726, "adx_3mo": 42.579011765135576, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -1.989657966460357, "stratHoldAlpha_3mo": 249.74950327454928, "stratHoldDrawdown_3mo": -0.4322484685870339, "Market Cap": 1010192129, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Country": "United States", "Sector": "Health Care", "IPO Year": 2018.0, "Name": "Allogene Therapeutics Inc.", "alpha%_1": 0.41584578352457535, "beta%_1": 0.9080577476013898, "drawup%_1": 0.9970803898545437, "natr%_1": 0.9998998800968963, "drawdown%_1": 0.07175583836052006, "stratHoldSharpe%_1": 0.37045298463978993, "stratHoldAlpha%_1": 0.3132318472678308, "stratHoldDrawdown%_1": 0.058818308996743285, "alpha%_3mo": 0.08181679666338071, "beta%_3mo": 0.9776246380166378, "drawup%_3mo": 0.8754112102618885, "natr%_3mo": 0.9998661672324919, "drawdown%_3mo": 2.646404280935264e-05, "stratHoldSharpe%_3mo": 0.030827999024101053, "stratHoldAlpha%_3mo": 0.002529557648204278, "stratHoldDrawdown%_3mo": 2.89779580557538e-05}